Related Articles

• Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis
• Association between epidermal growth factor receptor gene mutation status and short‑term efficacy of first‑line platinum‑containing chemotherapy in advanced non‑small cell lung cancer
• Characterization of distinct types of KRAS mutation and its impact on first‑line platinum‑based chemotherapy in Chinese patients with advanced non‑small cell lung cancer
• Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer
• Concurrent chemoradiotherapy with nedaplatin in patients with stage IIA to IVA cervical carcinoma